|Articles|October 19, 2009
Emerging Pharma Leadership Awards - Michelle Dipp
Advertisement
Michelle Dipp,
VP & Head of US Center of Excellence for External Drug Discovery,
GlaxoSmithKline
Download Adobe Flash Player
“The current economic environment is forcing the industry to adapt and change for the better in order to survive. I believe this will result in survival of the fittest, and biotech will be a source of pride and innovation in the US for decades to come.”Listen to the Podcast for more coverage.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Novartis Enters $12 Billion Definitive Merger Agreement to Acquire Avidity Biosciences
3
Study Claims Ozempic Lowers Biological Age
4
ACS Calls Obesity a Condition That Must Be Treated with Medication and Surgery
5
